Pamela Klein
About
In The Last Decade
Pamela Klein
28 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 81
- Oncology 770
- Molecular Biology 469
- Pulmonary and Respiratory Medicine 301
- Cancer Research 247
- Radiology, Nuclear Medicine and Imaging 244
Countries citing papers authored by Pamela Klein
This map shows the geographic impact of Pamela Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Klein more than expected).
Fields of papers citing papers by Pamela Klein
This network shows the impact of papers produced by Pamela Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Klein. The network helps show where Pamela Klein may publish in the future.
Co-authorship network of co-authors of Pamela Klein
This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Klein. A scholar is included among the top collaborators of Pamela Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Klein. Pamela Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 3 | |
| 3 | 7 | |
| 4 | 3 | |
| 5 | Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor | 1 |
| 6 | 4 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 117 | |
| 10 | 70 | |
| 11 | 5 | |
| 12 | 84 | |
| 13 | 202 | |
| 14 | 2 | |
| 15 | 1 | |
| 16 | 13 | |
| 17 | 234 | |
| 18 | 12 | |
| 19 | Weekly herceptin with navelbine in chemonaïve patients with HER2 positive metastatic breast cancer: A phase II multicenter trial | 2 |
| 20 | 32 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.